| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 165 | 1.747 | 1.012 | 1.722 | 1.632 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 165 | 1.803 | 1.027 | 1.722 | 1.733 | 0 | 0 |
| Total Expenses - EUR | 0 | 0 | 0 | 459 | 292 | 933 | 1.196 | 366 | 0 | 0 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | -294 | 1.511 | 95 | 527 | 1.367 | 0 | 0 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | -299 | 1.457 | 64 | 479 | 1.324 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Lifeblood Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 3.310 | 3.276 | 3.221 | 2.868 | 3.731 | 3.750 | 4.121 | 5.446 | 5.429 | 5.399 |
| Inventories | 616 | 609 | 877 | 1.213 | 1.516 | 1.025 | 0 | 96 | 95 | 95 |
| Receivables | 2.250 | 2.227 | 2.189 | 1.423 | 1.264 | 1.382 | 0 | 0 | 0 | 0 |
| Cash | 445 | 440 | 154 | 232 | 951 | 1.343 | 4.121 | 5.351 | 5.334 | 5.304 |
| Shareholders Funds | 2.722 | 2.695 | 2.649 | 2.301 | 3.714 | 3.681 | 4.078 | 5.415 | 5.398 | 5.368 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 588 | 582 | 572 | 566 | 17 | 69 | 43 | 31 | 31 | 31 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4789 - 4789" | |||||||||
| CAEN Financial Year |
4789
|
|||||||||
Comments - Lifeblood Srl